The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Cns Pharmaceuticals Inc’s current trading price is -98.71% away from its 52-week high, while its distance from the 52-week low is 9.54%. The stock’s price range for this period has been between $0.73 and $62.00 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.5 million for the day, a number notably lower than the average daily volume of 1.71 million over the last three months.
At present, Cns Pharmaceuticals Inc (CNSP) has a stock price of $0.8. In the previous session, the stock saw a rise, peaking at $7.0 after an opening price of $0.8. The day’s lowest price was $7.0, and it closed at $0.9.
Cns Pharmaceuticals Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $62.00 on 07/25/24, while the lowest value for the same period was recorded at $0.73 on 06/23/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Cns Pharmaceuticals Inc (CNSP) has experienced a quarterly decline of -2.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.37M and boasts a workforce of 5 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3982, with a change in price of -2.0800. Similarly, Cns Pharmaceuticals Inc recorded 1,184,941 in trading volume during the last 100 days, posting a change of -72.22%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CNSP stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.00.
CNSP Stock Stochastic Average
Cns Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 3.23%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 23.33%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 41.02% and 45.17%, respectively.
CNSP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -98.56%.However, over the last six months, we can see a stronger performance of -85.32%. Over the last 30 days, the price of CNSP has leaped by -3.50%. And in the last five days, it has fallen by -8.55%.
